A Study to Assess the Safety and Tolerability of Lucerastat in Subjects With Fabry Disease
Clinical trial NCT02930655 · COMPLETED
Trial details
- NCT number
- NCT02930655
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-02-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.